Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
What Does Index Level Tell You About The Market explains how the index reflects market conditions and helps you interpret momentum for decisions.
28,521 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A new tax idea targets big oil stock buybacks, but it could create more problems than it solves. This article explain...
When headlines warn of a strike and then show diplomacy's glow, oil markets react in real time. This guide outlines s...
Boeing, Honeywell, and 3M all fell in after-hours trading as Q4 results rolled out, signaling divergent paths. This p...
Richtech Robotics stock fell sharply in June after the company disclosed restatements. This guide breaks down what ha...
Microsoft is staring down a tough start to the year. Is the slide a red flag or a rare chance to buy a tech titan wit...
NVIDIA stock hovers in the mid-$170s, as traders debate whether the company can reach $500 per share by 2030 through ...
Tensions in the Middle East pushed mortgage rates higher, but U.S. homebuyers pressed on. A weekly tracker shows dema...
A surge in corporate bond issuance is tightening the funding path for the U.S. government, with investors chasing rec...
A marquee Bitcoin treasury deal tied to Adam Back’s 30,021 bitcoin is undergoing a financing overhaul as key backers ...
Ripple's latest private-market move values the company at $50 billion and signals confidence in its ecosystem, even a...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...